Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zebra Medical Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
Zebra Medical Technologies

Zebra Medical Technologies

Acquired

Zebra Medical Technologies, a California-based firm, revolutionizes patient care with immediate cellular imaging.

HQ
Mountain View, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Zebra Medical Technologies, founded in 2012 and headquartered in Menlo Park, California, is dedicated to transforming patient care through advanced clinical imaging. The company's core mission is to provide immediate visualization of cellular structures, thereby enhancing diagnostic accuracy and efficiency. Zebra Medical Technologies offers the VIO™ System, a hand-held device that digitizes cell images non-invasively and in real-time using a combination of multiphoton laser scanning and reflectance confocal microscopy. This technology aims to give physicians valuable cellular insights instantly.

Notable affiliated individuals include leading experts in medical imaging and technology innovation. Zebra Medical Technologies has garnered attention from prominent investors in the healthcare sector. Key achievements include the successful development and deployment of the VIO™ System, which has significantly impacted the way cellular imaging is conducted in clinical settings. The company's innovative approach has the potential to revolutionize diagnostic processes, making them faster and more accurate, ultimately improving patient outcomes.

Zebra Medical Technologies - Quick Facts

When was Zebra Medical Technologies founded?

Zebra Medical Technologies was founded in 2012.

Where is Zebra Medical Technologies' headquarters located?

Zebra Medical Technologies' headquarters is located in Mountain View, CA, US.

When was Zebra Medical Technologies' last funding round?

Zebra Medical Technologies' most recent funding round was for $1.2M (USD) in March 2022.

How much has Zebra Medical Technologies raised to-date?

As of Mar 16, 2022, Zebra Medical Technologies has raised a total of $12.7M (USD).

Zebra Medical Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Software
Main Product
  • Medical Imaging
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 3 more industry codes
NAICS
  • 330000Manufacturing
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries